Market Place
Sourcing Support
Veru to Present at the 2024 Cantor Global Healthcare Conference
11 Sep 2024 //
GLOBENEWSWIRE
Veru Names Steven Heymsfield Principal Investigator For Enobosarm Trial
15 May 2024 //
GLOBENEWSWIRE
Veru Fiscal Q2 2024 Results, Enobosarm Weight Loss Program
08 May 2024 //
GLOBENEWSWIRE
Veru Announces Date of 2024 Annual Meeting of Shareholders
01 Apr 2024 //
GLOBENEWSWIRE
Veru Announces FDA Clearance of IND Application to Initiate Ph 2b with Enobosarm
06 Feb 2024 //
GLOBENEWSWIRE
Veru Submits IND Application to FDA for the Development of Enobosarm
08 Jan 2024 //
GLOBENEWSWIRE
Veru to Host Investor Call on January 4th, 2024
19 Dec 2023 //
GLOBENEWSWIRE
Veru Reports Muscle Data from 5 Clinical Studies of Enobosarm
04 Oct 2023 //
GLOBENEWSWIRE
Veru Reports Clinical Data from the Discontinued ARTEST Study of Enobosarm
11 Sep 2023 //
GLOBENEWSWIRE
Veru Enters in Collaboration and Supply Agreement with Eli Lilly for Enobosarm
01 Feb 2022 //
GLOBENEWSWIRE
Veru Announces FDA Grant of FTD for Enobosarm in Metastatic Breast Cancer
10 Jan 2022 //
GLOBENEWSWIRE
GTx’s enobosarm flunks stress urinary incontinence trial
21 Sep 2018 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.